HIM
JAZZ icon

Hermes Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hermes Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-8,000
Closed -$1.18M – 243
2014
Q2 		$1.18M Sell
8,000
-2,500
-24% -$347K 0.03% 165
2014
Q1 		$1.46M Sell
10,500
-3,300
-24% -$497K 0.05% 143
2013
Q4 		$1.75M Sell
13,800
-2,600
-16% -$269K 0.05% 128
2013
Q3 		$1.51M Sell
16,400
-2,000
-11% -$161K 0.05% 133
2013
Q2 		$1.26M Buy
+18,400
New +$1.12M 0.05% 144

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Hermes Investment Management's JAZZ Position: Q3 2014 in Review

Hermes Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2014, closing a stake of 8,000 shares — an estimated $1.18M sold.

Hermes Investment Management first reported a position in JAZZ in Q2 2013 and held it in 5 quarters. The position peaked at $1.75M in Q4 2013. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2014.

  • Hermes Investment Management reported no remaining Jazz Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Hermes Investment Management sold 8,000 Jazz Pharmaceuticals shares in Q3 2014, an estimated $1.18M.
  • Hermes Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Hermes Investment Management's Jazz Pharmaceuticals position peaked at $1.75M in Q4 2013.
  • 325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2014.

Based on Hermes Investment Management's 13F filing for Q3 2014, filed 12 Nov 2014.